Time to Move

The system is not designed to handle this crisis.

Six in ten Americans have at least one chronic condition. More than ninety cents of every healthcare dollar treats conditions that could have been prevented or reversed upstream.

President Trump and Secretary Kennedy are at the helm. This is a generational opportunity — and it may not come again soon.

Official decision window: May 29 – June 12, 2026. Inside: the Burlison Bill, the congressional reconciliation path, the meeting at HHS, and the implementation plan. The mission is to align stakeholders, fund the messaging, lock the reconciliation path, and move immediately on implementation.

The President is in support. June 12 is the decision. We need your help.

Prepared May 29, 2026 · Updated to integrate Strategy Memo.

Why It's Needed

The Great American Health Plan creates a whole new category of tax-free health financing. President Trump and Secretary Kennedy brought the mandate for change. Congressman Burlison brought the bill.

Four Pillars

The MAHA movement's foundational insight is that the system has been shaped by corporate capture across food, pharmaceutical, and healthcare industries — producing a model built to manage disease after it appears, not prevent it before it begins.

The Scale of the Crisis

• $4.1 trillion annual cost of chronic disease
• Highest healthcare spend among wealthy nations, worst outcomes
• Children sicker than their parents at the same age
• Life expectancy declining after decades of improvement

Corporate Capture in Practice

• 60%+ of caloric supply is ultra-processed
• Agricultural chemicals banned in Europe still in use
• NIH funds patents over nutrition research
• Reimbursement rewards late-stage over prevention
• CPT-code universe built in the 1960s — never revised

Prevention is a cash market for the affluent. The majority are funneled into expensive late-stage intervention regardless of whether it is working.

Integrative medicine has been locked out for four decades. Naturopaths, acupuncturists, functional medicine doctors, osteopaths, health coaches, and nutritionists have been excluded from the billing architecture that determines what care can be delivered at scale. The barrier is not whether these therapies work — it is whether the system will recognize, code, and reimburse them. It doesn't. That's why we need the Burlison Bill: it creates a tax-free competitor for the captured insurance system.

What the Burlison Bill Covers

• Supplements (DSHEA) · Medical foods
• Dieticians, nutritionists, health coaches
• Air/water filtration, metabolic monitoring
• Autism & vaccine-injury therapeutics
• Full integrative practitioner spectrum

The Legislative Bridge

• Universal, unchained HSA for every American
• Eligible for full integrative/preventive spectrum
• First mechanism to fund the MAHA agenda at scale
• Nutrition treated as a valid medical expense

The Meeting That Decides Whether MAHA Becomes Law

Five independent forces are converging in one HHS meeting — and the outcome will determine whether the MAHA agenda is codified permanently or left vulnerable to reversal.

Phase 1 closes June 12. The GAHA memo is explicit: provisions not included now are nearly impossible to add later. This meeting is about locking the language into the budget resolution before the window closes.

The Reconciliation Phase Calendar

The GAHA Strategy Memo is the most specific timeline available — and more compressed than any prior analysis suggested. Three statutory decision points define the window and determine whether HSA provisions are carried into legislative text.

District Work Period likely cancelled. Members are expected to be in Washington and captive to the Hill, meaning the lobbying window is fully open during the make-or-break markup phase.

Source: GAHA Strategy Memo, June 1, 2026, under the Speaker Johnson / CMS Administrator Dr. Oz timetable.

Key Public Support Metrics

The Operational Team

This meeting requires decisions from four institutional roles. Each has a specific gate-keeping function before June 12.

What the Meeting Actually Decides

HHS willingness to endorse the bill must be established before the June 12 budget resolution deadline. The team answers the two questions all reconciliation-track legislation must clear: Can it score well? and Can it be passed?

Decision Items

• Klomp — CMS cost modeling on Medicare/Medicaid eligibility expansion; confirm TrumpRx codification is a legislative priority.
• Callahan — HHS willingness to endorse the bill before June 12.
• Andres — Byrd Rule exposure assessment and minimum viable Phase 1 language.
• Murphy — Can Arrington's committee include affordability directives in the FY27 resolution?
• Stursberg — Energy & Commerce subcommittee markup alignment for the June 15+ calendar.
• Brooks — CMS implementation feasibility and IRS/Treasury coordination status.

What OBBBA Already Did — Know This Cold

• Bronze/catastrophic ACA plans as HSA-compatible HDHPs
• DPC arrangements up to $150/month as HSA-qualified
• Permanent telehealth safe harbor
• HSA limits: $4,400 individual / $8,750 family (2026); $4,500 / $9,000 (2027)

What H.R. 8324 Adds Beyond OBBBA

• Strips the HDHP requirement entirely — universal eligibility
• Opens HSAs to Medicare and Medicaid enrollees
• Substantially raises contribution limits
• Expands qualified expenses to the full integrative/wellness list
• Price transparency enforcement mechanisms
• TrumpRx statutory codification

The delta between OBBBA and H.R. 8324 is where the policy fight lives. Don't claim credit for what's already enacted.

Implementation Strategy

Arrive with the tiered-eligibility analysis already done. It signals you understand the procedural reality and are prepared to negotiate strategically rather than defend every provision equally.

Tier 3 items generate the "saunas not premiums" press coverage and face the most Byrd Rule exposure. Negotiate on these while holding Tiers 1 and 2.

The OTC drug expansion in the CARES Act 2020 is your scoring precedent for Tier 2 supplement coverage.

Policy Track — Callahan, Brooks, Klomp

Implementation feasibility, cost modeling, TrumpRx codification. The CMS path for HSA expansion is partially mapped from OBBBA. The tariff-to-HSA mechanism needs a specific legal theory — Treasury/IRS guidance likely more viable than new appropriation. Come with an implementation sketch, not just vision.

Legislative Track — Andres, Murphy, Stursberg

Byrd Rule analysis and Phase 1 timeline. Which provisions have direct budgetary effect? What is the minimum viable version for the June 12 instructions? What do E&C and Ways & Means need to see to include provisions in the June 15+ markup?

The Expert Network & Coalition Assets

The GAHA Strategy Memo names an expert bench fully mobilized for rapid deployment to reporters and congressional staff during the June markup window.

The News Cycle & Strategic Environment

The Daily Caller story of May 26 is the live context. The documented pattern — an October survey showing 90% pharma concern that never reaches the White House; a December survey by the same Pfizer-connected pollster that does — is active news, creating political cover for course-correction that did not exist before.

Likely Criticism & Responses

• To coverage-loss attacks: the bill does not extend ACA coverage cuts. H.R. 8324 adds to what's available; it requires no high-deductible plan and replaces no coverage.
• To dark-money framing: name it first, then note 73% of likely voters support universal HSAs without knowing who funded the poll. The coalition is the electorate, not an industry lobby.
• To "HSAs help the wealthy": the tariff-seeding provision puts money in accounts before the enrollee contributes a dollar. 76% already support direct federal deposits to individuals.

Audience-Calibrated Messaging

• With Klomp: implementation, cost modeling, TrumpRx permanence. Frame codification as protecting work he has already done.
• With Callahan: the full political case reinforces the policy case — the leading Democratic attack is "failed to stand up to Big Pharma," and the answer is legislation, not messaging.
• With Andres & Murphy: the vote math. 67% of likely voters, 82% of Republicans, 60% of Democrats. Every competitive House district is winnable on this issue.

Lead with affordability: "Three-quarters of your constituents are intensely worried about what they pay for healthcare. This is the bill that gives them relief."

An American Tragedy

Six in ten American adults have at least one chronic condition; four in ten have two or more. Heart disease, diabetes, obesity, cancer, autoimmune disorders, dementia, and depression have become so prevalent that the medical establishment has largely normalized them — treating them as inevitable features of aging rather than the predictable consequences of food, farming, environmental, and financing systems that failed the same people at the same time.

The direct annual cost of chronic disease now exceeds $4.1 trillion. More than ninety cents of every healthcare dollar is spent treating conditions that could have been prevented or reversed upstream. The US spends more than any wealthy nation and produces worse outcomes across nearly every chronic disease category. Children are sicker than their parents were; life expectancy has been declining.

The Corporate Capture Problem

The food industry optimized for shelf life, palatability, and margin over nutrition — ultra-processed foods now exceed 60% of the caloric supply. The pharmaceutical industry captured the research agenda: NIH funding flows toward patentable interventions, medical education devotes fewer than twenty hours to nutrition, and reimbursement rewards procedures over prevention.

Prevention has been treated as optional. The financing system rewards intervention after disease appears, not the upstream work that could stop it.

Ninety percent of Americans are concerned about pharmaceutical industry influence on public policy — the highest score of any issue tested. Eighty-six percent support combating corporate capture in medicine.

The Forty-Year Lockout of Integrative Medicine

The practitioners in this space — naturopaths, acupuncturists, osteopaths, functional medicine doctors, health coaches, nutritionists, environmental medicine specialists — have fought for recognition for four decades. The fight is not primarily about clinical evidence; it is about billing architecture. The CPT-code universe was designed in the 1960s–70s around fee-for-service hospital and physician care and has never been fundamentally revised, because the institutions that benefit have consistently outweighed the practitioners and patients who would benefit from change.

The result is perverse: a patient who addresses the metabolic root causes of Type 2 diabetes through functional medicine may outperform one prescribed Metformin — but the functional visit is likely uncovered while the drug is covered. This is not a scientific judgment; it is a billing-architecture artifact, producing the same distorted outcomes for fifty years.

That's why we need the Great American Healthcare Plan. Let's go.